Ginkgo Bioworks Holdings, Inc. Announced Q1 2026 Earnings on May 7, 2026, Reporting "Revenue was $19 million in the first quarter of 2026"

Ginkgo Bioworks Holdings, Inc. reported its first quarter 2026 financial results.

Revenue was $19 million in the first quarter of 2026, down 49 percent compared to the first quarter of 2025.

Adjusted EBITDA in the first quarter of 2026 was negative $42 million, and cash burn in the first quarter of 2026 was $48 million.

The company reported a cash position of $373 million with no bank debt as of the first quarter of 2026.

Management stated that the focus for 2026 will be investing to win the category of autonomous labs.

The company closed the spin-off of its biosecurity unit into a new company called Perimeter on April 3, and Ginkgo now operates as a single segment.

The company is actively scaling its Nebula autonomous lab in Boston, expanding from 50 to 105 racks by the end of the month, and successfully launched its Cloud Lab service to the public.

For forward guidance, management reaffirmed their overall cash burn guidance for 2026, totaling $125 million to $150 million.

Management highlighted three new channels coming to their service business, including Amazon Biodiscovery, Benchling, and Tamarind Bio.

The company also discussed a project with OpenAI using GPT 5 that demonstrated a 40 percent improvement in the cost of cell-free protein synthesis over scientific state-of-the-art.